Bevacizumab
ACCRU RU261206I
Phase 2 mab completed
Quick answer
Bevacizumab for Metastatic Melanoma is a Phase 2 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Metastatic Melanoma
- Phase
- Phase 2
- Modality
- mab
- Status
- completed